MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 112 filers reported holding MACROGENICS INC in Q1 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,683,439 | -11.1% | 9,803,313 | +2.0% | 0.74% | +0.4% |
Q2 2023 | $51,413,035 | -25.4% | 9,609,913 | 0.0% | 0.73% | -26.7% |
Q1 2023 | $68,903,077 | +14.4% | 9,609,913 | +7.0% | 1.00% | +25.0% |
Q4 2022 | $60,255,217 | +137.7% | 8,979,913 | +22.6% | 0.80% | +119.8% |
Q3 2022 | $25,346,000 | +17.3% | 7,325,514 | 0.0% | 0.36% | +19.3% |
Q2 2022 | $21,610,000 | -66.5% | 7,325,514 | 0.0% | 0.30% | -59.3% |
Q1 2022 | $64,538,000 | -53.0% | 7,325,514 | -14.4% | 0.75% | -47.1% |
Q4 2021 | $137,396,000 | -23.2% | 8,560,462 | +0.2% | 1.42% | -22.0% |
Q3 2021 | $178,924,000 | -9.7% | 8,544,597 | +15.8% | 1.82% | -6.1% |
Q2 2021 | $198,121,000 | +3.2% | 7,376,026 | +22.4% | 1.93% | -4.8% |
Q1 2021 | $191,989,000 | +42.2% | 6,027,926 | +2.1% | 2.03% | +31.4% |
Q4 2020 | $134,978,000 | +1.4% | 5,904,517 | +11.8% | 1.55% | -15.9% |
Q3 2020 | $133,059,000 | -4.7% | 5,282,188 | +5.6% | 1.84% | -7.0% |
Q2 2020 | $139,659,000 | +292.1% | 5,002,116 | -18.3% | 1.98% | +186.1% |
Q1 2020 | $35,614,000 | -44.3% | 6,119,150 | +4.2% | 0.69% | -31.8% |
Q4 2019 | $63,902,000 | -2.3% | 5,873,356 | +14.6% | 1.01% | -16.7% |
Q3 2019 | $65,402,000 | -12.3% | 5,125,564 | +16.6% | 1.22% | -4.6% |
Q2 2019 | $74,588,000 | +424.9% | 4,395,264 | +456.1% | 1.27% | +62.9% |
Q1 2019 | $14,210,000 | +4.9% | 790,305 | -25.9% | 0.78% | -12.2% |
Q4 2018 | $13,551,000 | -12.7% | 1,066,993 | +47.3% | 0.89% | -9.5% |
Q3 2018 | $15,529,000 | +26.0% | 724,302 | +21.3% | 0.98% | -6.3% |
Q2 2018 | $12,326,000 | -13.0% | 596,913 | +6.0% | 1.05% | -25.1% |
Q1 2018 | $14,169,000 | +32.1% | 563,151 | -0.2% | 1.40% | +25.4% |
Q4 2017 | $10,724,000 | +33.9% | 564,401 | +30.3% | 1.12% | +33.8% |
Q3 2017 | $8,007,000 | +44.5% | 433,299 | +36.9% | 0.84% | +27.8% |
Q2 2017 | $5,540,000 | -2.2% | 316,418 | +3.9% | 0.66% | -13.2% |
Q1 2017 | $5,666,000 | +233.9% | 304,597 | +267.0% | 0.76% | +117.0% |
Q4 2016 | $1,697,000 | -31.7% | 83,000 | 0.0% | 0.35% | -22.5% |
Q3 2016 | $2,483,000 | +10.8% | 83,000 | 0.0% | 0.45% | +6.7% |
Q2 2016 | $2,240,000 | +44.0% | 83,000 | 0.0% | 0.42% | +49.3% |
Q1 2016 | $1,556,000 | – | 83,000 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
XTX Topco Ltd | 53,269 | $248,234 | 0.04% |